New collaboration!

BIOASTER collaborates with ZYNNON to advance VOC-based detection and identification of pathogens in clinical and industrial microbiology settings   BIOASTER – Lyon, France, ZYNNON AG – Schindellegi, Switzerland, September 26,...

New sequencer @BIOASTER

BIOASTER is pleased to announce the recent acquisition of the newest GridION, a sequencer of third generation entirely developed by Oxford Nanopore Technologies. This installation is the logical consequence of...

ERA4TB:Progess and Achievements

BIOASTER is proud to be part of ERA4TB (European Regimen Accelerator for #Tuberculosis) project, a public-private initiative devoted to accelerating the development of new treatment regimens for tuberculosis. The ERA4TB...